Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome
IBS
Screening and Identification of Abnormal Expression Proteins and miRNA From Colonic Mucosa of Patients With Irritable Bowel Syndrome.
1 other identifier
observational
180
0 countries
N/A
Brief Summary
In the investigators study, the investigators will focus on the screening of the related proteins and miRNA to IBS in order to reveal the possible clues or molecular mechanism for this disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2006
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 8, 2009
CompletedFirst Posted
Study publicly available on registry
December 9, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFebruary 11, 2011
December 1, 2006
5.6 years
December 8, 2009
February 10, 2011
Conditions
Keywords
Eligibility Criteria
IBS patients (IBS-D and IBS-C)and healthy control
You may qualify if:
- Patients with symptoms meeting Rome III criteria for diagnosis of IBS-C and IBS-D
You may not qualify if:
- Patients with organic illnesses or a history of major abdominal surgery
- Major psychotic episode, mental retardation or dementia
- Pregnant women and lactational women
- Postinfectious IBS, PI-IBS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Wang WF, Li X, Guo MZ, Chen JD, Yang YS, Peng LH, Wang YH, Zhang CY, Li HH. Mitochondrial ATP 6 and 8 polymorphisms in irritable bowel syndrome with diarrhea. World J Gastroenterol. 2013 Jun 28;19(24):3847-53. doi: 10.3748/wjg.v19.i24.3847.
PMID: 23840124DERIVED
Biospecimen
The investigators enrolled IBS-D and IBS-C patients on the Rome III criteria and healthy volunteers as normal control group. Biopsies were taken from the cecum and sigmoid colon under direct vision. Five pieces were taken separately at each site. Four pieces were processed by cold saline water and frozen in liquid nitrogen immediately while the other one was fixed in formalin and then embedded in paraffin three days later.
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
YANG Yun-sheng, MD
Chinese PLA General Hospital
- PRINCIPAL INVESTIGATOR
ZHANG Chun-yan, doctor
Chinese PLA General Hospital
- PRINCIPAL INVESTIGATOR
WANG Weifeng, doctor
Chinese PLA General Hospital
- PRINCIPAL INVESTIGATOR
YAO XIN, DOCTOR
Chinese PLA General Hospital
- PRINCIPAL INVESTIGATOR
PENG LIHUA, DOCTOR
Chinese PLA General Hospital
- PRINCIPAL INVESTIGATOR
YU YUANZI, DOCTOR
Chinese PLA General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 8, 2009
First Posted
December 9, 2009
Study Start
January 1, 2006
Primary Completion
August 1, 2011
Study Completion
December 1, 2012
Last Updated
February 11, 2011
Record last verified: 2006-12